Agalsidase Beta Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 35 mg
Reference Brands: Fabrazyme (USA/EU)
Category: Orphan Drugs
Agalsidase beta is a recombinant form of the human enzyme alpha-galactosidase A, used in enzyme replacement therapy for Fabry disease. It helps break down globotriaosylceramide (GL-3), a fatty substance that accumulates in the cells of patients with this inherited lysosomal storage disorder. By reducing GL-3 buildup, Agalsidase beta helps alleviate symptoms such as pain, kidney dysfunction, and cardiovascular complications associated with Fabry disease. Agalsidase beta is available in Injection and strengths such as 35 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Agalsidase beta is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Agalsidase beta can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Agalsidase beta is used to treat Fabry disease, a rare inherited disorder caused by the buildup of a fatty substance called globotriaosylceramide (GL-3) in the body's cells.
Agalsidase beta is made from a recombinant form of the human enzyme alpha-galactosidase A, produced through recombinant DNA technology in Chinese hamster ovary (CHO) cells.
The trade name of Agalsidase beta is Fabrazyme.
Agalsidase beta is made by Sanofi Genzyme.
The generic name of the product is Agalsidase beta.
The brand name of Agalsidase beta is Fabrazyme.
Agalsidase beta is manufactured by Sanofi Genzyme in the United States and the Netherlands.
Related Products
Arimoclomol
Strength:
47 mg, 62mg, 93mg
Form: Capsules
Reference Brands: MIPLYFFA (USA)
View Details
Doxecitine + Doxribtimine
Strength:
2g+2g
Form: Oral Solution
Reference Brands: Kygevvi (USA)
View Details
Emapalumab-Lzsg
Strength:
10 mg/2 mL, 50 mg/10 mL
Form: Injection
Reference Brands: Gamifant (USA/EU)
View Details
Migalastat Hydrochloride
Strength:
123 mg
Form: Capsules
Reference Brands: Galafold (USA/EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
